NASDAQ$INGN

Inogen Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Inogen's Q4 2021 financial results were announced, showing a slight increase in total revenue compared to the same period in 2020.

Inogen reported a 3.3% increase in total revenue for Q4 2021, reaching $76.4 million. The growth was driven by domestic direct-to-consumer sales and rental revenue, while international business-to-business sales also contributed positively. The company reported a net loss of $22.9 million, impacted by a non-cash income tax provision expense.

  • Total revenue increased by 3.3% year-over-year to $76.4 million.
  • Domestic direct-to-consumer revenue increased by 23.3% year-over-year to $33.0 million.
  • Rental revenue increased by 39.4% year-over-year to $13.0 million.
  • The company reported a net loss of $22.9 million, or $1.01 per diluted share.

Headline financials

Total Revenue

$76.4M

Previous: $74M+3.3%
EPS (adj)

-$1.01

Previous: -$0.23-339.1%
Capital Expenditures

$675K

Previous: $1.03M-34.7%
Free Cash Flow

$5.82M

Previous: $15.2M-61.6%
Net Income

-$22.9M

Previous: -$5.12M-346.7%
Operating Income

-$6.67M

Previous: -$5.52M-20.8%
Gross Profit

$38.6M

Previous: $34.1M+13.3%
Cash & Equivalents

$236M

Previous: $212M+11.1%
Total Assets

$490M

Previous: $462M+6.0%
Stock-Based Comp

$2.4M

Previous: $2.09M+14.5%

Revenue & EPS history

Inogen · Revenue · Quarterly

$76.4M

Q4 2021+3.3%vs Q4 2020
Beat estimate in 10 of 16 quarters(63%)
ActualEstimate

Forward guidance

The Company continues to see ongoing uncertainty in the business mainly related to supply chain disruptions, in addition to increased cost of critical components, and the continued and varying impacts of the COVID-19 pandemic. As a result, the Company is not providing detailed guidance for 2022, but expects total revenue in the first quarter of 2022 to be similar to the fourth quarter of 2021 and expects 2022 full year-over-year revenue growth to be in the mid-single digit range versus 2021.

Tailwinds

  • Expects total revenue in the first quarter of 2022 to be similar to the fourth quarter of 2021.
  • Expects 2022 full year-over-year revenue growth to be in the mid-single digit range versus 2021.
  • Actively working with its suppliers both in the regular and open market channels to continue to procure necessary semiconductor chips.
  • Working on certain product redesign opportunities.
  • Plans to continue to make investments in clinical research, research and development, commercial operations and building the necessary infrastructure and capabilities to support future durable revenue growth and margin expansion.

Headwinds

  • Ongoing uncertainty in the business mainly related to supply chain disruptions.
  • Increased cost of critical components.
  • Continued and varying impacts of the COVID-19 pandemic.
  • Semiconductor chip shortage experienced across many industries has and will likely continue to have a negative impact on its ability to manufacture products.
  • Expects negative Adjusted EBITDA and operating and net losses in the first quarter of 2022 and operating and net losses for the full year, reflecting the anticipated supply-constrained environment, increased cost of goods sold and incremental growth investments versus the prior year.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

-0.7%

Avg return

Earnings day

-2.0%

Avg return

5 days after

-2.0%

Avg return

30 days after

49%

26 / 53 earnings

Positive

+35.5%

Q2 2024

Best reaction

-32.2%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.4%-5.3%-11.0%
Q4 2025+4.3%+5.8%+6.0%
Q3 2025-0.6%+0.9%-1.3%
Q1 2025-11.5%-14.4%-8.1%
Q4 2024-14.8%-14.6%-28.6%
Q3 2024+15.9%+9.1%-0.7%
Q2 2024+35.5%+50.6%+43.0%
Q1 2024+14.6%+17.7%+17.7%
Q4 2023-32.2%-24.3%-13.0%
Q3 2023-1.3%-8.1%+10.0%
Q2 2023-14.6%-18.7%-20.8%
Q1 2023-6.1%-19.3%-21.9%
Q4 2022-31.4%-32.4%-46.4%
Q3 2022-12.5%-10.0%-0.8%
Q2 2022-6.9%-7.3%-6.3%
Q1 2022-2.2%-7.8%+2.0%
Q4 2021+12.6%+25.3%+13.5%
Q3 2021-6.0%-7.3%-21.6%
Q2 2021-22.8%-16.8%-22.1%
Q1 2021-3.5%-2.4%-12.8%
Q4 2020+4.6%+5.4%-4.2%
Q3 2020-7.1%+9.8%+33.0%
Q2 2020+16.4%+17.0%-6.5%
Q1 2020-21.4%-20.1%-24.2%
Q4 2019+10.2%+5.4%+26.4%
Q3 2019+17.3%+19.7%+24.4%
Q2 2019-15.4%-18.5%-20.9%
Q1 2019-28.8%-22.2%-31.8%
Q4 2018-26.4%-25.9%-35.1%
Q3 2018-18.8%-22.6%-24.8%
Q2 2018+7.7%+6.3%+21.3%
Q1 2018+21.0%+18.7%+26.7%
Q4 2017-9.3%-8.4%-7.8%
Q3 2017+16.1%+12.9%+15.0%
Q2 2017-5.6%-3.9%+0.3%
Q1 2017+0.2%-2.6%+11.9%
Q4 2016+6.8%+6.0%+11.4%
Q3 2016+13.0%+15.8%+22.3%
Q2 2016+0.9%+9.3%+8.9%
Q1 2016-6.6%
Q4 2015+20.6%
Q3 2015-1.8%
Q2 2015+13.0%
Q1 2015+4.9%
Q4 2014+1.8%
Q4 2012+1.8%
Q3 2013-1.7%
Q3 2014+6.0%
Q2 2014+3.6%
Q2 2013+3.6%
Q1 2013+12.7%
Q1 2014+12.7%
Q4 2013-1.0%
Q3 2012

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro